Shubhankar K. Singh
Patna, BR, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Potential efficacy of repurposed drugs for treating drug-resistant visceral leishmaniasis.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: May 05, 2026
Insights into drug resistance in Leishmania: Mechanisms, therapeutics, and clinical case studies.
Journal: ADMET & DMPK
Published: September 03, 2025
Luliconazole Potentiates Efficacy of Miltefosine Against Leishmania donovani.
Journal: Drug development research
Published: July 25, 2025
Association of Post Kala-Azar Dermal Leishmaniasis pathogenesis with prolonged sunlight (ultraviolet radiations) exposure in VL endemic population of Bihar.
Journal: Scientific reports
Published: February 18, 2025
Molecular and immunohistochemical alterations in fluoride-induced neurological impediment in adult rats.
Journal: Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)
Published: June 19, 2024
Therapeutic Potential of Quercetin-Loaded Nanoemulsion against Experimental Visceral Leishmaniasis: In Vitro/Ex Vivo Studies and Mechanistic Insights.
Journal: Molecular pharmaceutics
Published: August 18, 2022
An introduction to dynamic nucleoporins in Leishmania species: Novel targets for tropical-therapeutics.
Journal: Journal of parasitic diseases : official organ of the Indian Society for Parasitology
Published: January 12, 2022
In vitro and in silico analysis of L. donovani enoyl acyl carrier protein reductase - A possible drug target.
Journal: Journal of biomolecular structure & dynamics
Published: August 09, 2020
Corrigendum: Leishmania-Specific Promiscuous Membrane Protein Tubulin Folding Cofactor D Divulges Th1/Th2 Polarization in the Host via ERK-1/2 and p38 MAPK Signaling Cascade.
Journal: Frontiers in immunology
Published: July 07, 2020
Leishmania-Specific Promiscuous Membrane Protein Tubulin Folding Cofactor D Divulges Th1/Th2 Polarization in the Host via ERK-1/2 and p38 MAPK Signaling Cascade.
Journal: Frontiers in immunology
Published: October 23, 2019
A randomized, open-label study to evaluate the efficacy and safety of liposomal amphotericin B (AmBisome) versus miltefosine in patients with post-kala-azar dermal leishmaniasis.
Journal: Indian journal of dermatology, venereology and leprology
Published: May 01, 2019
Synthesis, characterization, and mechanistic studies of a gold nanoparticle-amphotericin B covalent conjugate with enhanced antileishmanial efficacy and reduced cytotoxicity.
Journal: International journal of nanomedicine
Published: December 11, 2018
Last Updated: 09/26/2026